Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKD 13.9
(17.0%)
HKD 13.9
(17.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 716.91 Million | 533.88 Million | 354.55 Million | 253.54 Million |
| Cost of Revenue | 210.87 Million | 142.13 Million | 107.11 Million | 86.54 Million |
| Gross Profit | 506.03 Million | 391.75 Million | 247.44 Million | 166.99 Million |
| Operating Expenses | 776.31 Million | 997.75 Million | 772.89 Million | 547.25 Million |
| Selling, General and Administrative Expenses | 349.08 Million | 313.66 Million | 83.39 Million | 62.05 Million |
| Research and Development Expenses | 474.37 Million | 699.16 Million | 558.48 Million | 276.3 Million |
| Other Expenses | -47.13 Million | -15.07 Million | 131.01 Million | 208.89 Million |
| Cost and Expenses | 987.19 Million | 1.13 Billion | 880 Million | 633.8 Million |
| Operating Income | -270.28 Million | -606 Million | -525.45 Million | -380.25 Million |
| Interest Expense | 99.84 Million | 56.13 Million | 39.42 Million | 22.53 Million |
| Income Tax Expense | 2.79 Million | 804 Thousand | 39.95 Million | 66.27 Million |
| Earnings before Tax | -380.15 Million | -601.35 Million | -545.64 Million | -476.69 Million |
| Net Income | -382.95 Million | -602.15 Million | -585.59 Million | -542.97 Million |
| Earnings Per Share Basic | -0.96 | -1.00 | -1.48 | -1.37 |
| Earnings Per Share Diluted | -0.96 | -1.00 | -1.48 | -1.37 |
| Weighted Average Shares Outstanding | 398.31 Million | 601.94 Million | 396.68 Million | 396.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 398.31 Million | 601.94 Million | 396.68 Million | 396.68 Million |
| Gross Margin | 0.71 | 0.73 | 0.70 | 0.66 |
| EBIT Margin | -0.15 | -0.77 | -1.06 | -1.26 |
| Profit Margin | -0.53 | -1.13 | -1.65 | -2.14 |
| EBITDA | -104.72 Million | -413.31 Million | -378.12 Million | -318.44 Million |
| Earnings Before Tax Margin | -0.38 | -1.14 | -1.48 | -1.50 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 205.24 Million | 205.24 Million | 716.91 Million | 195.03 Million | 195.03 Million | 163.41 Million |
| Cost of Revenue | 49.26 Million | 49.26 Million | 210.87 Million | 57.73 Million | 57.73 Million | 45.26 Million |
| Gross Profit | 155.98 Million | 155.98 Million | 506.03 Million | 137.3 Million | 137.3 Million | 118.15 Million |
| Operating Expenses | 148.62 Million | 148.62 Million | 812.1 Million | 203.57 Million | 208.42 Million | 192.26 Million |
| Selling, General and Administrative Expenses | 72.54 Million | 72.54 Million | - | 101.02 Million | 101.02 Million | 73.51 Million |
| Research and Development Expenses | 80.83 Million | 80.83 Million | - | 113.2 Million | 113.2 Million | 123.98 Million |
| Other Expenses | -4.76 Million | -4.76 Million | 9.68 Million | -10.64 Million | - | - |
| Cost and Expenses | 197.88 Million | 197.88 Million | 1.02 Billion | 261.3 Million | 266.15 Million | 237.53 Million |
| Operating Income | 7.36 Million | 7.36 Million | -270.28 Million | -66.27 Million | -67.62 Million | -78.12 Million |
| Interest Expense | - | - | 99.84 Million | - | - | 52.77 Million |
| Income Tax Expense | 1.79 Million | 1.79 Million | 2.79 Million | 1.18 Million | 1.18 Million | 210 Thousand |
| Earnings before Tax | -23.53 Million | -23.53 Million | -380.15 Million | -95.38 Million | -95.38 Million | -94.69 Million |
| Net Income | -25.33 Million | -25.33 Million | -382.95 Million | -96.57 Million | -96.57 Million | -94.9 Million |
| Earnings Per Share Basic | -0.06 | -0.06 | - | -0.24 | -0.24 | -0.24 |
| Earnings Per Share Diluted | -0.06 | -0.06 | - | -0.24 | -0.24 | -0.24 |
| Weighted Average Shares Outstanding | 398.27 Million | 398.27 Million | 398.31 Million | 398.24 Million | 398.24 Million | 398.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 398.26 Million | 398.26 Million | 398.31 Million | 398.24 Million | 398.24 Million | 398.37 Million |
| Gross Margin | 0.76 | 0.76 | 0.71 | 0.70 | 0.70 | 0.72 |
| EBIT Margin | 0.23 | 0.23 | - | -0.20 | -0.20 | -0.22 |
| Profit Margin | -0.12 | -0.12 | -0.53 | -0.50 | -0.50 | -0.58 |
| EBITDA | 46.5 Million | 46.5 Million | - | -39.72 Million | -39.72 Million | -36.09 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | -0.38 | -0.34 | -0.35 | -0.48 |
HPAIW
3923
JVTSF
XIACF
1143
0390